Table 2.

Coefficient of change in eGFR per year in the two years following initiation of systemic therapy (average change in eGFR per year and for specific patient groups per year).

Patient group	Coefficient of eGFR change per year (mL/min/1.73m2)	95% CI: lower	95% CI: upper	p-value
Whole cohort (unadjusted)	+1.03	−1.64	+3.70	0.23
Nephrectomy prior to systemic therapy	+2.30	−1.66	+6.26	0.52
Metastatic cancer at the point of diagnosis	−0.18	−5.25	+4.89	0.648
Average eGFR < 60 prior to systemic therapy	−1.02	−6.55	+4.50	0.473